Vanessa Wolfeler

Bio:

Vanessa is the CEO of SERB, a global pharmaceutical company with a fast-growing portfolio of more than 70 products providing vital therapies to overlooked patients. She brings more than 20 years of experience in the global healthcare and biotechnology industries, and deep expertise in strategy, commercial operations, business development, and leading global teams. Vanessa most recently served as head of U.S. respiratory and gastrointestinal franchise for Sanofi, where she led teams responsible for two critical launches in the US, and was previously Sanofi’s head of the global rare blood disorders franchise. Prior to that, she held senior roles at Vertex, Shire, Baxalta, AstraZeneca, and GSK, across US, UK and France. Originally from Paris, Vanessa received her PharmD and Master of Science in Toxicology degrees from the Université Paris Sud and holds a master’s degree in marketing from HEC School of Business in Paris.